15-Deoxy-Δ12,14-Prostaglandin J2 and Troglitazone Regulation of the Release of Phospholipid Metabolites, Inflammatory Cytokines and Proteases from Human Gestational Tissues

Placenta

Volumn 27, Issue 11-12, 2006, Pages 1060-1072

  Lappas, M ^a   Permezel, M ^a   Rice, G E ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Cytokines; Fetal membranes; Human pregnancy; MAPK; NF B; Placenta; PPAR ; Prostaglandins; Protease

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 2 CHLORO 5 NITROBENZANILIDE; ANTIINFLAMMATORY AGENT; DNA; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOLIPASE A2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOTAGMIN; TROGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

AMNION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHORION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DECIDUA; DELIVERY; ENZYME INHIBITION; ENZYME RELEASE; EXTRACELLULAR MATRIX; FETUS; HUMAN; HUMAN TISSUE; INFLAMMATION; LABOR; METABOLITE; PLACENTA; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ANILIDES; CHROMANS; CYTOKINES; DINOPROST; DINOPROSTONE; EXTRAEMBRYONIC MEMBRANES; FEMALE; HUMANS; INFLAMMATION; INTERLEUKINS; LIPOPOLYSACCHARIDES; MATRIX METALLOPROTEINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PHOSPHOLIPASES A; PHOSPHOLIPIDS; PLACENTA; PPAR GAMMA; PREGNANCY; PROSTAGLANDIN D2; THIAZOLIDINEDIONES;

EID: 33748746245     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2005.11.009     Document Type: Article

References (36)

1. Rice G.E. Cytokines and the initiation of parturition. Front Horm Res 27 (2001) 113-146
2. 2 isozymes in pregnancy and parturition. Prostaglandins Leukot Essent Fatty Acids 70 (2004) 87-100
3. Kniss D.A. Cyclooxygenases in reproductive medicine and biology. J Soc Gynecol Invest 6 (1999) 285-292
4. Fata J.E., Ho A.T., Leco K.J., Moorehead R.A., and Khokha R. Cellular turnover and extracellular matrix remodeling in female reproductive tissues: functions of metalloproteinases and their inhibitors. Cell Mol Life Sci 57 (2000) 77-95
5. Lappas M., Permezel M., Georgiou H.M., and Rice G.E. Nuclear factor kappa B regulation of pro-inflammatory cytokines in human gestational tissues in vitro. Biol Reprod 67 (2002) 668-673
6. Lappas M., Permezel M., and Rice G.E. N-Acetyl-cysteine inhibits phospholipid metabolism, pro-inflammatory cytokine release, protease activity, and nuclear factor-κB deoxyribonucleic acid-binding activity in human fetal membranes in vitro. J Clin Endocrinol Metab 88 (2003) 1723-1729
7. Lappas M., Permezel M., Georgiou H.M., and Rice G.E. Regulation of phospholipase isozymes by nuclear factor-κB in human gestational tissues in vitro. J Clin Endocrinol Metab 89 (2004) 2365-2372
8. 27 human trophoblasts. J Soc Gynecol Invest 6 (1999) 52A
9. 2 and troglitazone. J Clin Endocrinol Metab 87 (2002) 4667-4672
10. Ackerman W.E., Zhang X.L., Rovin B.H., and Kniss D.A. Modulation of cytokine-induced cyclooxygenase 2 expression by PPARγ ligands through NF-κB signal disruption in human WISH and amnion cells. Biol Reprod 73 (2005) 527-535
11. 2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferators-activated receptors γ and δ and nuclear factor κB. Mol Pharmacol 68 (2005) 169-178
12. 2 inhibits interleukin-1β-induced nuclear factor-B in human amnion and myometrial cells: mechanisms and implications. J Clin Endocrinol Metab 90 (2005) 3534-3543
13. Barak Y., Nelson M.C., Ong E.S., Jones Y.Z., Ruiz-Lozano P., Chien K.R., et al. PPAR-γ is required for placental, cardiac, and adipose tissue development. Mol Cell 4 (1999) 585-595
14. Schaiff W.T., Carlson M.G., Smith S.D., Levy R., Nelson D.M., and Sadovsky Y. Peroxisome proliferator-activated receptor-γ modulates differentiation of human trophoblast in a ligand-specific manner. J Clin Endocrinol Metab 85 (2000) 3874-3881
15. Capparuccia L., Marzioni D., Giordano A., Fazioli F., De Nictolis M., Busso N., et al. PPAR-γ expression in normal human placenta, hydatidiform mole and choriocarcinoma. Mol Hum Reprod 8 (2002) 574-579
16. Dunn-Albanese L.R., Ackerman W.E., Xie Y.B., Iams J.D., and Kniss D.A. Reciprocal expression of peroxisome proliferator-activated receptor-gamma and cyclooxygenase-2 in human term parturition. Am J Obstet Gynecol 190 (2004) 809-816
17. 2, a ligand for peroxisome proliferator-activated receptor-γ, induces apoptosis in JEG-3 choriocarcinoma cells. Biochem Biophys Res Commun 262 (1999) 579-585
18. 2 derivative induces apoptosis in amnion derived WISH cells. J Soc Gynecol Invest 6 (1999) 75A
19. 2 receptor, peroxisome proliferator activated receptor-γ (PPAR-γ) is expressed in human gestational tissues and is functionally active in JEG-3 choriocarcinoma cells. Placenta 21 (2000) 436-440
20. Tarrade A., Schoonjans K., Pavan L., Auwerx J., Rochette-Egly C., Evain-Brion D., et al. PPAR-γ/RXR-α heterodimers control human trophoblast invasion. J Clin Endocrinol Metab 86 (2001) 5017-5024
21. Wang Q., Fujii H., and Knipp G.T. Expression of PPAR and RXR isoforms in the developing rat and human term placentas. Placenta 23 (2002) 661-671
22. Leesnitzer L.M., Parks D.J., Bledsoe R.K., Cobb J.E., Collins J.L., Consler T.G., et al. Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry 41 (2002) 6640-6650
23. Inoue I., Katayama S., Takahashi K., Negishi K., Miyazaki T., Sonoda M., et al. Troglitazone has a scavenging effect on reactive oxygen species. Biochem Biophys Res Commun 235 (1997) 113-116
24. Lappas M., Permezel M., and Rice G.E. Release of pro-inflammatory cytokines and 8-isoprostane from placenta, adipose tissue and skeletal muscle from normal pregnant women and women with gestational diabetes mellitus. J Clin Endocrinol Metab 89 (2004) 5627-5633
25. Marx N., Sukhova G., Murphy C., Libby P., and Plutzky J. Macrophages in human atheroma contain PPARγ: differential-dependent PPARγ expression and reduction of MMP-9 activity through PPARγ activation in mononuclear phagocytes in vitro. Am J Pathol 153 (1998) 17-23
26. Marx N., Schonbeck U., Lazar M.A., Libby P., and Plutzky J. PPARγ activators inhibit gene expression and migration in human vascular smooth muscle cells. Circ Res 83 (1998) 1097-1103
27. Straus D.S., and Glass C.K. Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med Res Rev 21 (2001) 185-210
28. 2 derivatives really playing the part?. Cell Signal 14 (2002) 573-583
29. 2: the anti-inflammatory prostaglandin?. Clin Immunol 114 (2005) 100-109
30. Gilroy D.W., Colville-Nash P.R., Willis D., Chivers J., and Paul-Clark M.J. Inducible COX may have anti-inflammatory properties. Nat Med 5 (1999) 698-701
31. Willoughby D., Lawrence T., and Colville-Nash P. Cyclooxygenase-2 in experimental models of inflammation. In: Vane J.R., and Botting R.M. (Eds) (2001), William Harvey Press, Cambridge 95-127
32. 2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-κB-p300 pathway independent of peroxisome proliferator-activated receptor gamma. J Immunol 173 (2004) 5196-5208
33. Jiang C., Ting A.T., and Seed B. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 391 (1998) 82-86
34. 2 and rosilglitazone suppress Janus kinase-STAT inflammatory signaling through induction of suppressor of cytokine signaling 1 (SOCS1) and SOCS3 in glia. J Biol Chem 278 (2003) 14747-14752
35. Ricote M., Li A.C., Willson T.M., Kelly C.J., and Glass C.K. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391 (1998) 79-82
36. 2) isoprostanes - unique, highly reactive products of arachidonate peroxidation. Antioxid Redox Signal 7 (2005) 210-220